Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 163
Filtrar
1.
Appetite ; : 107504, 2024 May 18.
Artículo en Inglés | MEDLINE | ID: mdl-38768926

RESUMEN

The dynorphin peptides are the endogenous ligands for the kappa opioid receptor (KOR) and regulate food intake. Administration of dynorphin-A1-13 (DYN) in the paraventricular hypothalamic nucleus (PVN) increases palatable food intake, and this effect is blocked by co-administration of the orexin-A neuropeptide, which is co-released with DYN in PVN from neurons located in the lateral hypothalamus. While PVN administration of DYN increases palatable food intake, whether it increases food-seeking behaviors has yet to be examined. We tested the effects of DYN and norBNI (a KOR antagonist) on the seeking and consumption of sucrose using a progressive ratio (PR) and demand curve (DC) tasks. In PVN, DYN did not alter the sucrose breaking point in the PR task nor the elasticity or intensity of demand for sucrose in the DC task. Still, DYN reduced the delay in obtaining sucrose and increased licks during sucrose intake in the PR task, irrespective of the co-administration of orexin-A. In PVN, norBNI increased the delay in obtaining sucrose and reduced licks during sucrose intake in the PR task while reducing elasticity but not intensity of demand in the DC task. However, subcutaneous norBNI reduced the breaking point for sucrose and increased the delay in obtaining sucrose in the PR task while reducing the elasticity of demand. Together, these data show different effects of systemic and PVN blockade of KOR on food-seeking, consummatory behaviors, and incentive motivation for sucrose and suggest that KOR activity in PVN is necessary but not sufficient to drive seeking behaviors for palatable food.

2.
Eur J Surg Oncol ; 49(11): 107072, 2023 11.
Artículo en Inglés | MEDLINE | ID: mdl-37722286

RESUMEN

INTRODUCTION: Microscopically positive resection margins (R1) are associated with poorer outcomes in patients with colorectal cancer. However, different definitions of R1 margins exist. It is unclear to what extent the definitions used in everyday clinical practice differ within and between nations. This study sought to investigate variations in the definition of R1 margins in colorectal cancer and the importance of margin status in clinical decision-making. MATERIALS AND METHODS: A 14-point survey was developed by members of The European Society of Surgical Oncology (ESSO) Youngs Surgeons and Alumni Club (EYSAC) Research Academy targeting all members of the multidisciplinary team (MDT) treating patients with colorectal cancer. The survey was distributed on social media, in ESSO's monthly newsletter and via national societies. RESULTS: In total, 137 responses were received. Most respondents were from Europe (89.7%), with the majority from Denmark (56.9%). Less than 2/3 of respondents defined R1 margins as the presence of viable cancer cells ≤1 mm of the margin. Only 60% reported that subdivisions of R1 margins (primary tumour vs tumour deposit vs metastatic lymph node) are routinely available. More than 20% of respondents reported that pathology reports are not routinely reviewed at MDT meetings. Less than half of respondents considered margin status in decision-making for type and duration of adjuvant chemotherapy in Stage III colon cancer. CONCLUSION: The definitions and perceived clinical importance of microscopically positive margins in patients with colorectal cancer appear to vary. Adoption of an international dataset for pathology reporting may help to standardise current practices.


Asunto(s)
Neoplasias del Colon , Oncología Quirúrgica , Humanos , Márgenes de Escisión , Encuestas y Cuestionarios , Europa (Continente) , Estudios Retrospectivos
3.
Neurosci Biobehav Rev ; 152: 105288, 2023 09.
Artículo en Inglés | MEDLINE | ID: mdl-37331611

RESUMEN

The opioid receptors (OR) regulate food intake. Still, despite extensive pre-clinical research, the overall effects and individual contribution of the mu (MOR), kappa (KOR), and delta (DOR) OR subtypes to feeding behaviors and food intake remain unclear. To address this, we conducted a pre-registered systematic search and meta-analysis of rodent dose-response studies to evaluate the impact of central and peripheral administration of non-selective and selective OR ligands on intake, motivation, and choice of food. All studies had a high bias risk. Still, the meta-analysis confirmed the overall orexigenic and anorexigenic effects of OR agonists and antagonists, respectively. Our results support a larger orexigenic role for central MOR agonists among OR subtypes and that peripheral OR antagonists reduce motivation for and intake of preferred foods. In binary food choice studies, peripheral OR agonists selectively increase the intake of fat-preferred foods; in contrast, they did not increase the intake of sweet carbohydrate-preferred foods. Overall, these data support that OR regulation of intake, motivation, and choice is influenced by food macronutrient composition.


Asunto(s)
Motivación , Receptores Opioides , Analgésicos Opioides/farmacología , Ingestión de Alimentos , Conducta Alimentaria , Ligandos , Receptores Opioides mu
4.
ESMO Open ; 8(1): 100772, 2023 02.
Artículo en Inglés | MEDLINE | ID: mdl-36681013

RESUMEN

BACKGROUND: Trastuzumab increases the incidence of cardiac events (CEs) in patients with breast cancer (BC). Dual blockade with pertuzumab (P) and trastuzumab (T) improves BC outcomes and is the standard of care for high-risk human epidermal growth factor receptor 2 (HER2)-positive early BC patients. We analyzed the cardiac safety of P and T in the phase III APHINITY trial. PATIENTS AND METHODS: Left ventricular ejection fraction (LVEF) ≥ 55% was required at study entry. LVEF assessment was carried out every 3 months during treatment, every 6 months up to month 36, and yearly up to 10 years. Primary CE was defined as heart failure class III/IV and a significant decrease in LVEF (defined as ≥10% from baseline and to <50%), or cardiac death. Secondary CE was defined as a confirmed significant decrease in LVEF, or CEs confirmed by the cardiac advisory board. RESULTS: The safety analysis population consisted of 4769 patients. With 74 months of median follow-up, CEs were observed in 159 patients (3.3%): 83 (3.5%) in P + T and 76 (3.2%) in T arms, respectively. Most CEs occurred during anti-HER2 therapy (123; 77.4%) and were asymptomatic or mildly symptomatic decreases in LVEF (133; 83.6%). There were two cardiac deaths in each arm (0.1%). Cardiac risk factors indicated were age > 65 years, body mass index ≥ 25 kg/m2, baseline LVEF between 55% and <60%, and use of an anthracycline-containing chemotherapy regimen. Acute recovery from a CE based on subsequent LVEF values was observed in 127/155 patients (81.9%). CONCLUSIONS: Dual blockade with P + T does not increase the risk of CEs compared with T alone. The use of anthracycline-based chemotherapy increases the risk of a CE; hence, non-anthracycline chemotherapy may be considered, particularly in patients with cardiovascular risk factors.


Asunto(s)
Neoplasias de la Mama , Anciano , Femenino , Humanos , Antraciclinas/efectos adversos , Neoplasias de la Mama/tratamiento farmacológico , Volumen Sistólico , Trastuzumab , Función Ventricular Izquierda
5.
Infect Genet Evol ; 102: 105291, 2022 08.
Artículo en Inglés | MEDLINE | ID: mdl-35490957

RESUMEN

Rickettsial diseases have seen a re-emergence in the Americas in the last few decades, with concerning morbidity, mortality and economic implications that result from loss of productivity, income, curbs in liberal trade agreements, and reduction in agricultural practices. The aim of this study is to determine the socioecological determinants and seroprevalence for Rickettsia typhi and Rickettsia rickettsii among residents of Teabo, a rural community of Yucatán, Mexico. Sociodemographic data and serum samples were obtained from 180 consenting participants. Antibody titers for R. typhi and R. rickettsii were determined by indirect immunofluorescence assay (IFA). Participants also submitted tick samples collected from their residential area. We conducted logistic regression models to evaluate the association between exposure variables and seroprevalence. Rhipicephalus sanguineus s.l. (37%; n = 65), and Amblyomma cajennense Fabricius (17%; n = 29) were the predominant tick species in peri-domestic areas. Out of the 180 participants, there was significantly higher seroprevalence of R. typhi (n = 77; 46%) compared to R. rickettsii [n = 27, 15%, (p < 0.05)]. Pearson's chi-square test of independence revealed significant differences in R. rickettsii seroprevalence by gender (X2 [n = 175, df = 4, (p < 0.001)] = 180.26), level of education, (X2 [n = 180, df = 4, (p < 0.001)] = 44.0), and by tick species found in residential area, (X2 [n = 180, df = 4, (p = 0.050)] = 9.48). After adjusting for other variables in a logistic regression model, for each unit increase in the number of dogs present in the residential area, there was a 27% increase in the odds of human seroprevalence for R. typhi IgG (AOR = 1.27, 95% CI: 1.01-1.63). Compared to study participants living in residential areas with a 'low' height of vegetation, those living in residential areas with a 'medium' height of vegetation had 2.5 times greater odds of human seroprevalence for R. typhi IgG (AOR = 2.51, 95% CI: 1.19-5.40). Potentially modifiable existing factors in the peri-domestic area may constitute a high-risk source of seroprevalence for rickettsial antibodies among residents of the rural community of Teabo, Yucatán, Mexico.


Asunto(s)
Enfermedades de los Perros , Rhipicephalus sanguineus , Rickettsia , Animales , Enfermedades de los Perros/microbiología , Perros , Humanos , Inmunoglobulina G , México/epidemiología , Rhipicephalus sanguineus/microbiología , Población Rural , Estudios Seroepidemiológicos
6.
J Neurophysiol ; 127(5): 1289-1297, 2022 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-35353616

RESUMEN

The complexity of the center of pressure (COP) provides important information regarding the underlying mechanisms of postural control. The relationships between COP complexity and balance performance are not fully established and might depend on the task constraints and the filtering decomposition of the COP signal. This study assessed COP complexity under different task constraints and it was assessed if emergent dynamics of COP fluctuations differ according to fractional components of COP related to peripheral or central adjustments. One hundred and sixty-two participants performed two sitting balance tasks. Accuracy was required by following a target that moved in the mediolateral (ML) or in the anteroposterior (AP) axis. Complexity dynamics of COP were addressed through detrended fluctuation analysis (DFA) in the axis constrained by accuracy requirements and in the one nonconstrained. Decomposition of COP components was applied by low-pass, band-pass, and high-pass filters. DFA of low-pass and band-pass components of COP in the constrained axis were small-to-moderately related (r = 0.190-0.237) to balance performance. DFA of the high-pass component of the COP exhibited the opposite relationship (r = -0.283 to -0.453) in both axes (constrained and nonconstrained). This study evidences that COP complexity is linked to better performance. This positive relationship complexity/performance is observed in the low- and mid-frequency components of the COP. These components might be related to central mechanisms of postural control. The lack of relationships between the different frequencies analyzed in the study suggests that they are capturing different components of postural control.NEW & NOTEWORTHY The relationship between the complexity of the center of pressure (COP) and balance performance is not fully established. The task constraints and the filtering decomposition of the COP could influence this relationship. COP complexity is related to a better balance performance only in low frequencies and midfrequencies of the COP. The different frequencies measure different postural control components. Filtering decomposition should be explored in future studies to address the underlying mechanisms of postural control.


Asunto(s)
Equilibrio Postural , Humanos
7.
Mar Environ Res ; 169: 105399, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-34175523

RESUMEN

Overfishing is a key stressor in many coral reefs, affecting their function and ecosystem services. In the Gulf of California, 50 years of artisanal and recreational fishing have removed most of the largest and most vulnerable fish species, the Espiritu Santo Archipelago (ESA) is a marine protected area (MPA) where artisanal and recreational fishing are allowed in most of the natural reefs, while the artificial reefs (wrecks) are fully protected. An important question under such circumstances is whether artificial reefs can serve as surrogate habitats for the natural reefs. To address this question, we characterized the fish community (species richness, abundance, differences in taxonomic structure) and analyzed the obtained data by multivariate ordination and similarity analysis. The highest species richness was found in the artificial reefs, with total of 83 species, of which 21 species were exclusive. Contrary to the species richness, the total fish abundance was 20% higher at the natural reefs. The fish assemblages of the artificial reefs differ significantly from those of the natural reefs. The natural reefs of the ESA are dominated by few fish species from families of lower trophic levels. In contrast, the studied shipwrecks provide refuge to commercially important fish species (such as Snappers, Triggerfish, Jacks, and Groupers) including threatened species. The different fish compositions on the natural and artificial reefs is likely to be the outcome of differential fishing pressure. The non-fished areas (wrecks) of the ESA may represent a good strategy for reef restoration, enhanced fishing grounds (via spillover) and fishing management. However, the fish community structure of the artificial reefs differs from natural rocky reefs of the ESA, and therefore, should not be considered as surrogate habitats for natural reefs. The results point out the need to reassess the management effectiveness of the natural reefs of the ESA.


Asunto(s)
Conservación de los Recursos Naturales , Ecosistema , Animales , Arrecifes de Coral , Explotaciones Pesqueras , Peces , Alimentos Marinos
8.
Mol Genet Metab Rep ; 25: 100637, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-32874916

RESUMEN

Congenital Disorders of Glycosylation (CDG) are scarcely reported from Latin America. We here report on a Mexican mestizo with a multi-systemic syndrome including neurological involvement and a type I transferrin (Tf) isoelectric focusing (IEF) pattern. Clinical exome sequencing (CES) showed known compound missense variants in PMM2 c.422G > A (p.R141H) and c.395 T > C (p.I132T), coding for the phosphomanomutase 2 (PMM2). PMM2 catalyzes the conversion of mannose-6-P to mannose-1-P required for the synthesis of GDP-Man and Dol-P-Man, donor substrates for glycosylation reactions. This is the third reported Mexican CDG patient and the first with PMM2-CDG. PMM2 has been recently identified as one of the top 10 genes carrying pathogenic variants in a Mexican population cohort.

9.
Oxf Med Case Reports ; 2020(4): omz144, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-32477581

RESUMEN

Cardiopulmonary resuscitation (CPR) is often conducted with mechanical devices, such as Lund University Cardiac Arrest System in the setting of cardiac arrest during coronary catheterization, to enable effective chest compressions for a prolonged period. Certain injuries from such devices are common such as skin lesions, sternal and rib fractures. Others are rarer, such as visceral injury to the heart, major vessels, lung, liver, spleen and stomach. Major liver injuries have been previously reported but were universally fatal. Here, we report the first case of a capsular liver tear post-mechanical CPR, requiring immediate laparotomy and primary repair, resulting in patient survival with a normal cardiovascular and neurological and outcome.

11.
Rev Esp Quimioter ; 33(3): 180-186, 2020 Jun.
Artículo en Español | MEDLINE | ID: mdl-32232318

RESUMEN

OBJECTIVE: Health care-related infections are a public health problem, among them surgical site infection (SSI) are the most frequent in hospitals. The objetive of this study was to assess the effect of the compliance to antibiotic prophylaxis protocol on the incidence of surgical site infection in hysterectomized patients. METHODS: A prospective cohort study was carried out between October 2009 and December 2018. The incidence of SSI was studied after a maximum period of 30 days from the moment of surgery. The degree of adequacy of antibiotic prophylaxis in hysterectomy and the effect of its inadequacy on the incidence of infection was evaluated using relative risk (RR) adjusted with a logistic regression model. RESULTS: A total of 1,025 interventions were studied in 1,022 women. The cumulative incidence of SSI was 2,1% (n = 22). The most frequent etiology of infection was Escherichia coli (23.1%) and Proteus mirabilis (23.1%). Antibiotic prophylaxis was indicated in 1,014 interventions (98.9%) being administered in 1,009 of them (99.5%). The adherence to the protocol was 92,5%. The main cause of non-compliance was the time of onset (40.9%), followed by the choice of the antibiotic (35.2%). The effect of inadequate prophylaxis on the incidence of infection was RR = 0.9; 95% CI 0.2-3.9; p> 0.05. CONCLUSIONS: The adequacy of antibiotic prophylaxis was very high, with a low incidence of surgical site infection. No association was found between adequacy of prophylaxis and incidence of infection in hysterectomy. The continuous improvement of epidemiological surveillance in gynecology should be emphasized.


Asunto(s)
Profilaxis Antibiótica/normas , Histerectomía/normas , Adulto , Anciano , Estudios de Cohortes , Femenino , Adhesión a Directriz , Humanos , Histerectomía/métodos , Incidencia , Persona de Mediana Edad , Estudios Prospectivos , Infección de la Herida Quirúrgica/epidemiología , Infección de la Herida Quirúrgica/microbiología , Infección de la Herida Quirúrgica/prevención & control
12.
Acta pediatr. esp ; 78(1/2): e6-e9, ene.-feb. 2020. tab
Artículo en Español | IBECS | ID: ibc-202305

RESUMEN

INTRODUCCIÓN: La relación médico-paciente asiste a un nuevo paradigma: la búsqueda de información médico-sanitaria por los pacientes, en ocasiones antes o después de acudir a consulta médica. MATERIAL Y MÉTODOS: Estudio transversal, observacional, no experimental. Encuesta en las consultas externas de un hospital general de área a los padres/madres que acudían por primera vez. RESULTADOS: Contestaron 220 progenitores. El 90% disponían de conexión a internet en su domicilio y el 98% en su móvil. Solo el 38% buscaron información antes de acudir y el 25% la buscarían al llegar a su domicilio. El 34% de los encuestados encontró información relacionada con su problema y al 26% les resultó adecuada. Al 38% les hubiera gustado que tras la visita su médico les hubiese recomendado alguna página web de calidad y a un 80% les parecía una buena idea que el servicio de pediatría contase con su propia página web. CONCLUSIÓN: Cada día es más frecuente que los pacientes busquen información médico-sanitaria en internet antes de acudir a consulta y por ello los profesionales sanitarios y los propios servicios deben estar preparados para ofrecer información de calidad por estos medios


INTRODUCTION: The doctor-patient relationship attends a new paradigm: the search for medical-health information by patients, sometimes before or after going to a doctor's office. MATERIAL AND METHODS: Cross-sectional, observational, non-experimental study. Survey in the outpatient clinics of a general area hospital to parents who came for the first time. RESULTS: 220 parents answered. 90% had Internet connection at home and 98% on their mobile. Only 38% sought information before going and 25% would seek it when they arrived at their home. 34% of respondents found information related to their problem and 26% found it appropriate. 38% would have liked that after the visit their doctor had recommended a quality website and 80% thought it was a good idea for the pediatric service to have its own website. CONCLUSIONS: Every day it is more frequent for patients to seek medical-health information on the Internet before going to consultation and for that reason health professionals and the services themselves must be prepared to offer quality information through these means


Asunto(s)
Humanos , Masculino , Femenino , Acceso a Internet/estadística & datos numéricos , Relaciones Médico-Paciente , Derivación y Consulta , Comunicación , Encuestas y Cuestionarios
13.
Eur J Surg Oncol ; 45(9): 1515-1519, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-31085024

RESUMEN

As part of its mission to promote the best surgical care for cancer patients, the European Society of Surgical Oncology (ESSO) has been developing multiple programmes for clinical research along with its educational portfolio. This position paper describes the different research activities of the Society over the past decade and an action plan for the upcoming five years to lead innovative and high quality surgical oncology research. ESSO proposes to consider pragmatic research methodologies as a complement to randomised clinical trials (RCT), advocates for increased funding and operational support in conducting research and aims to enable young surgeons to be active in research and establish partnerships for translational research activities.


Asunto(s)
Investigación Biomédica/tendencias , Ensayos Clínicos como Asunto , Asistencia Sanitaria Culturalmente Competente , Proyectos de Investigación/tendencias , Oncología Quirúrgica/tendencias , Europa (Continente) , Humanos , Sociedades Médicas
14.
Clin. transl. oncol. (Print) ; 21(1): 64-74, ene. 2019. tab
Artículo en Inglés | IBECS | ID: ibc-183345

RESUMEN

The goal of this article is to provide recommendations about the management of muscle-invasive (MIBC) and metastatic bladder cancer. New molecular subtypes of MIBC are associated with specific clinical-pathological characteristics. Radical cystectomy and lymph node dissection are the gold standard for treatment and neoadjuvant chemotherapy with a cisplatin-based combination should be recommended in fit patients. The role of adjuvant chemotherapy in MIBC remains controversial; its use must be considered in patients with high-risk who are able to tolerate a cisplatin-based regimen, and have not received neoadjuvant chemotherapy. Bladder-preserving approaches are reasonable alternatives to cystectomy in selected patients for whom cystectomy is not contemplated either for clinical or personal reasons. Cisplatin-based combination chemotherapy is the standard first-line protocol for metastatic disease. In the case of unfit patients, carboplatin-gemcitabine should be considered the preferred first-line chemotherapy treatment option, while pembrolizumab and atezolizumab can be contemplated for individuals with high PD-L1 expression. In cases of progression after platinum-based therapy, PD-1/PD-L1 inhibitors are standard alternatives. Vinflunine is another option when anti-PD-1/PD-L1 therapy is not possible. There are no data from randomized clinical trials regarding moving on to immuno-oncology agents


No disponible


Asunto(s)
Humanos , Carcinoma de Células Transicionales/terapia , Neoplasias de la Vejiga Urinaria/terapia , Neoplasias de los Músculos/terapia , Antineoplásicos Inmunológicos/uso terapéutico , Antineoplásicos/uso terapéutico , Invasividad Neoplásica/patología , Neoplasias de los Músculos/secundario , Cistectomía/métodos , Pautas de la Práctica en Medicina
15.
Clin Transl Oncol ; 21(1): 64-74, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30565086

RESUMEN

The goal of this article is to provide recommendations about the management of muscle-invasive (MIBC) and metastatic bladder cancer. New molecular subtypes of MIBC are associated with specific clinical-pathological characteristics. Radical cystectomy and lymph node dissection are the gold standard for treatment and neoadjuvant chemotherapy with a cisplatin-based combination should be recommended in fit patients. The role of adjuvant chemotherapy in MIBC remains controversial; its use must be considered in patients with high-risk who are able to tolerate a cisplatin-based regimen, and have not received neoadjuvant chemotherapy. Bladder-preserving approaches are reasonable alternatives to cystectomy in selected patients for whom cystectomy is not contemplated either for clinical or personal reasons. Cisplatin-based combination chemotherapy is the standard first-line protocol for metastatic disease. In the case of unfit patients, carboplatin-gemcitabine should be considered the preferred first-line chemotherapy treatment option, while pembrolizumab and atezolizumab can be contemplated for individuals with high PD-L1 expression. In cases of progression after platinum-based therapy, PD-1/PD-L1 inhibitors are standard alternatives. Vinflunine is another option when anti-PD-1/PD-L1 therapy is not possible. There are no data from randomized clinical trials regarding moving on to immuno-oncology agents.


Asunto(s)
Neoplasias de los Músculos/terapia , Guías de Práctica Clínica como Asunto/normas , Neoplasias de la Vejiga Urinaria/terapia , Ensayos Clínicos como Asunto , Terapia Combinada , Manejo de la Enfermedad , Humanos , Neoplasias de los Músculos/secundario , Invasividad Neoplásica , Pronóstico , Sociedades Médicas , Neoplasias de la Vejiga Urinaria/patología
16.
Clin. transl. oncol. (Print) ; 20(12): 1493-1501, dic. 2018. tab
Artículo en Inglés | IBECS | ID: ibc-173756

RESUMEN

Cancer cases are growing in an exponential way, likewise the prices of new cancer drugs. Continuing in this way, in the near future, it will be impossible to provide optimum care for all cancer patients. Therefore, it is important to establish mechanisms that enable the National Health Systems to provide the best options of treatment, either through the elaboration of decision-binding frameworks or through other initiatives that guarantee the best quality care for all oncology patients to overcome, in the best possible way, this difficult illness. Here, we review current proposals that have been established by different cancer organizations worldwide, their similarities, their differences and whether they are helpful in a real clinical setting. Facing present reality and despite these organizations’ huge efforts, these proposals are not being implemented at all and it does not seem feasible that they will in the short run. In the same way, we support and argue why oncologists should have a crucial and a preponderant role to establish the best way of guaranteeing an equal access to the latest oncology care


No disponible


Asunto(s)
Humanos , Oncología Médica/tendencias , Tecnología de Alto Costo , Neoplasias/economía , Equidad en el Acceso a los Servicios de Salud , Accesibilidad a los Servicios de Salud/tendencias , Costos de la Atención en Salud/tendencias , Rol Profesional
17.
Ann Oncol ; 29(12): 2313-2327, 2018 12 01.
Artículo en Inglés | MEDLINE | ID: mdl-30307465

RESUMEN

The molecular landscape of squamous cell carcinoma of the head and the neck (SCCHN) has been characterized and actionable or targetable genomic alterations have been identified. However, targeted therapies have very limited activity in unselected SCCHN, and the current treatment strategy is still based on tumor location and disease stage and not on tumor biology. Trying to select upfront the patients who will benefit from a specific treatment might be a way to improve patients' outcome. With the objective of optimizing the activity of targeted therapies and immunotherapy, we have designed an umbrella biomarker-driven study dedicated to recurrent and/or metastatic SCCHN patients (EORTC-1559-HNCG, NCT03088059). In this article, we review not only the different trial designs for biomarker-driven studies with their respective advantages and opportunities but also the potential pitfalls that led to the design of the EORTC-1559-HNCG protocol. We also discuss the scientific and logistic challenges of biomarker-driven trials.


Asunto(s)
Antineoplásicos/uso terapéutico , Biomarcadores de Tumor/genética , Neoplasias de Cabeza y Cuello/tratamiento farmacológico , Recurrencia Local de Neoplasia/tratamiento farmacológico , Carcinoma de Células Escamosas de Cabeza y Cuello/tratamiento farmacológico , Antineoplásicos/farmacología , Biomarcadores de Tumor/antagonistas & inhibidores , Biomarcadores de Tumor/metabolismo , Biopsia , Ensayos Clínicos como Asunto , Supervivencia sin Enfermedad , Europa (Continente) , Neoplasias de Cabeza y Cuello/genética , Neoplasias de Cabeza y Cuello/mortalidad , Neoplasias de Cabeza y Cuello/patología , Humanos , Terapia Molecular Dirigida/métodos , Recurrencia Local de Neoplasia/genética , Recurrencia Local de Neoplasia/mortalidad , Recurrencia Local de Neoplasia/patología , Selección de Paciente , Medicina de Precisión/métodos , Supervivencia sin Progresión , Proyectos de Investigación , Carcinoma de Células Escamosas de Cabeza y Cuello/genética , Carcinoma de Células Escamosas de Cabeza y Cuello/mortalidad , Carcinoma de Células Escamosas de Cabeza y Cuello/patología
18.
Clin Transl Oncol ; 20(12): 1493-1501, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-29796999

RESUMEN

Cancer cases are growing in an exponential way, likewise the prices of new cancer drugs. Continuing in this way, in the near future, it will be impossible to provide optimum care for all cancer patients. Therefore, it is important to establish mechanisms that enable the National Health Systems to provide the best options of treatment, either through the elaboration of decision-binding frameworks or through other initiatives that guarantee the best quality care for all oncology patients to overcome, in the best possible way, this difficult illness. Here, we review current proposals that have been established by different cancer organizations worldwide, their similarities, their differences and whether they are helpful in a real clinical setting. Facing present reality and despite these organizations' huge efforts, these proposals are not being implemented at all and it does not seem feasible that they will in the short run. In the same way, we support and argue why oncologists should have a crucial and a preponderant role to establish the best way of guaranteeing an equal access to the latest oncology care.


Asunto(s)
Antineoplásicos/economía , Oncología Médica/economía , Neoplasias/tratamiento farmacológico , Neoplasias/economía , Humanos , Oncología Médica/métodos
19.
J Vector Borne Dis ; 55(4): 258-264, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30997885

RESUMEN

Rickettsia are intracellular vector-borne bacteria, which are the etiologic agent of severe infections that could inflict death to their host. The intracellular behaviour of Rickettsia makes the study of its genetics, proteomics and cellular processes very difficult. Hence, isolation remains an important experimental technique that permits the obtention of important yields of bacteria, useful for a broad range of experiments. Isolation of Rickettsia using passages in animals or embryonated eggs has been described for long time; however, it was until the 1990s that faster and more feasible approaches for cell culture were developed. Current isolation approaches are mainly based on shell vial culture, that varies according to the media, atmosphere or temperature conditions. These variations have allowed the establishment of isolates from different pathogenic and non-pathogenic Rickettsia species, using arthropod, animal or human samples. Purification method of bacteria has also witnessed changes alongside the quantification of its load in the resulting isolates, from the laborious and time consuming plaque assays, to the routinary use of real-time polymerase chain reaction (qPCR), which is faster and more accurate. This review discusses various approaches that have been used for the isolation and purification of different Rickettsia species along with the mention of some successful examples. It indicated that a successful strategy for the isolation of Rickettsia requires a careful selection of media, cell lines and culture conditions which now are not as time consuming as used to be.


Asunto(s)
Técnicas Bacteriológicas , Rickettsia/crecimiento & desarrollo , Rickettsia/aislamiento & purificación , Animales , Línea Celular , Medios de Cultivo , Humanos , Ratones , Reacción en Cadena en Tiempo Real de la Polimerasa , Garrapatas/microbiología
20.
Eur J Surg Oncol ; 42(8): 1115-22, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27241924

RESUMEN

AIMS: Quality assurance (QA) in a surgical trial must be planned and implemented from study development to completion. Elements of quality must be consistently described in a protocols, case report forms (CRFs) and reported in publications. The purpose of this review was to evaluate the most common surgical parameters and how consistently they were described in EORTC study documents where surgery was included. This was the preliminary step in mapping out the challenges of developing a surgical QA strategy in EORTC. METHODS: A systematic review of EORTC surgical protocols from 1980 to 2013 was performed. Two independent reviewers selected and reviewed the protocols. Data extraction was done using a questionnaire developed by EORTC QA committee. The results were compared across the time period. RESULTS: The most common quality parameters described in protocols were surgical technique, definition of resectability, surgical margins and methods of assessing adverse events using the Common Terminology Criteria for Adverse Event (CTCAE). However, these were not consistently reported in publications. A general improvement in the method of protocol development was observed since year 2000 after standardization measures by EORTC. A new surgical chapter template has been proposed. CONCLUSION: There is a need to consistently define and report surgical parameters from protocol development to publication as a first step to QA. A standard surgical chapter in the EORTC protocol template can help address this need. A framework to consistently implement QA for future surgical trials is needed and the rationale for this is described in this review.


Asunto(s)
Investigación Biomédica/normas , Protocolos Clínicos , Neoplasias/cirugía , Garantía de la Calidad de Atención de Salud , Oncología Quirúrgica/normas , Europa (Continente) , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...